Theradaptive Awarded DOD Clinical Trial Award

Theradaptive OsteoAdapt in Cage

Theradaptive was awarded a U.S. Department of Defense (DOD) Clinical Trial Award of up to $7.4 million with options, subject to FDA approval to begin phase I/II clinical studies. The award recognizes the scientific merit of Theradaptive’s work in targeted regenerative therapeutics to create safer and more efficacious treatments for patients with...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us